Ms. Beschle leads the Kyruus product lines within RevSpring following their acquisition, overseeing more than 20 product offerings across a globally distributed team of 27 that supports more than 740 health systems, 2,400 ambulatory care organizations and 110 health plan brands in patient access and financial engagement. As part of Kyruus prior to the acquisition, Ms. Beschle contributed to $24 million across products under her responsibility and drove a 20-point increase in customer net promoter score, from 44 to 64. Her work centers on bringing previously separate capabilities into a more cohesive product experience, including development of RevSpring’s model context protocol suite with a national directory grounding layer designed to bridge advanced AI models with provider quality data, real-time availability, insurance networks and cost transparency to enable trustworthy care navigation at scale. She is a registered inventor on the “RxEffect” technology patent and has prior involvement with Women in Product and the Women Business Leaders of the U.S. Health Care Industry Foundation. RevSpring earned “Best in KLAS for Patient Financial Engagement” in 2025 and 2026.
